Yoshida Y - Search Results

1

Processing of hepatitis B virus surface antigen expressed by recombinant Oka varicella vaccine virus.

Shiraki K, Ochiai H, Matsui S, Aiba N, Yoshida Y, Okuno T, Yamanishi K, Takahashi M. Shiraki K, et al. Among authors: yoshida y. J Gen Virol. 1992 Jun;73 ( Pt 6):1401-7. doi: 10.1099/0022-1317-73-6-1401. J Gen Virol. 1992. PMID: 1318942

2

Phase II study of recombinant human granulocyte-macrophage colony-stimulating factor in myelodysplastic syndrome and aplastic anemia.

Takahashi M, Yoshida Y, Kaku K, Masaoka T, Moriyama Y, Nakanishi S, Kaneko T, Shibata A, Miwa S. Takahashi M, et al. Among authors: yoshida y. Acta Haematol. 1993;89(4):189-94. doi: 10.1159/000204521. Acta Haematol. 1993. PMID: 8212999 Clinical Trial.

3

Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) after chemotherapy in patients with non-Hodgkin's lymphoma; a placebo-controlled double blind phase III trial.

Kaku K, Takahashi M, Moriyama Y, Nakahata T, Masaoka T, Yoshida Y, Shibata A, Kaneko T, Miwa S. Kaku K, et al. Among authors: yoshida y. Leuk Lymphoma. 1993 Oct;11(3-4):229-38. doi: 10.3109/10428199309087000. Leuk Lymphoma. 1993. PMID: 8260897 Clinical Trial.

4

Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced granulocytopenia in patients with malignancies.

Moriyama Y, Takahashi M, Kaku K, Yoshida Y, Masaoka T, Nakanishi S, Kaneko T, Shibata A, Miwa S. Moriyama Y, et al. Among authors: yoshida y. Acta Haematol. 1993;89(2):70-5. doi: 10.1159/000204490. Acta Haematol. 1993. PMID: 8503246 Clinical Trial.

5

Effects of long-term treatment with recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome.

Yoshida Y, Nakahata T, Shibata A, Takahashi M, Moriyama Y, Kaku K, Masaoka T, Kaneko T, Miwa S. Yoshida Y, et al. Leuk Lymphoma. 1995 Aug;18(5-6):457-63. doi: 10.3109/10428199509059645. Leuk Lymphoma. 1995. PMID: 8528053 Clinical Trial.

6

Topical treatment of cutaneous herpes simplex virus-1 infection in mice with a specially formulated caffeine gel (Cafon).

Yamamura J, Koyasu M, Sato H, Kurokawa M, Yoshida Y, Amahabu Y, Shiraki K. Yamamura J, et al. Among authors: yoshida y. J Dermatol Sci. 1996 Apr;12(1):50-5. doi: 10.1016/0923-1811(95)00464-5. J Dermatol Sci. 1996. PMID: 8740461

7

Prophylactic treatment of cytomegalovirus infection with traditional herbs.

Yukawa TA, Kurokawa M, Sato H, Yoshida Y, Kageyama S, Hasegawa T, Namba T, Imakita M, Hozumi T, Shiraki K. Yukawa TA, et al. Among authors: yoshida y. Antiviral Res. 1996 Oct;32(2):63-70. doi: 10.1016/0166-3542(95)00978-7. Antiviral Res. 1996. PMID: 8891165

8

Efficacy of Cafon gel on cutaneous infection with herpes simplex virus (HSV)-2 and acyclovir-resistant HSV in mice.

Yoshida Y, Yamamura J, Sato H, Koyasu M, Obara Y, Sekiguchi H, Kawana T, Shiraki K. Yoshida Y, et al. J Dermatol Sci. 1996 Dec;13(3):237-41. doi: 10.1016/s0923-1811(97)89474-1. J Dermatol Sci. 1996. PMID: 9023706

9

Augmentation of natural killer cell activity induced by cytomegalovirus infection in mice treated with FK506.

Kageyama S, Matsui S, Hasegawa T, Yoshida Y, Sato H, Yamamura J, Kurokawa M, Yamamoto H, Shiraki K. Kageyama S, et al. Among authors: yoshida y. Acta Virol. 1997 Aug;41(4):215-20. Acta Virol. 1997. PMID: 9391652

10

[A case of pulmonary arteriovenous fistula presenting as multiple brain abscesses after a sustained period without treatment].

Yoshida Y, Harada S, Arai N, Matsui S, Maruyama M, Kobayashi M. Yoshida Y, et al. Nihon Kyobu Shikkan Gakkai Zasshi. 1997 Oct;35(10):1104-7. Nihon Kyobu Shikkan Gakkai Zasshi. 1997. PMID: 9465623 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,026 results

Search Page

Filters